The weekly programme “View into Science” interviews the first Slovenian grantee ever, Dr Nedjeljka Zagar, about her ERC funded research in meteorology. In this 25 minutes-long programme, she says that by combining current observations of the atmosphere with modelling, she expects to provide a better understanding of weather and climate variability. The reporter mentions that the innovativeness of her project could be made possible by her 4-year ERC grant.
ERC in the Press
The smallest laboratory able to simulate complex quantum phenomena lies in a chip, reports the Italian news agency AGI. The system uses photons, i.e. light, to process data. This research project is a first step towards the computer processors of the future, the kind that will have revolutionary capacity and speed of calculations. The chip has been developed thanks to the collaboration of different Italian research institutions and is funded by Fabio Sciarrino's ERC Starting Grant (3D-QUEST project). Related studies have recently been published in Nature Communications and Nature Photonics.
Polish agency PAP gathers comments of some Polish ERC grantees presented in the video ‘ERC: when the dreams come true’.
The agency quotes ERC grantees Maciej Konacki and Justyna Olko explaining why ERC grants are worth applying for.
Only few Polish researchers participate in ERC competitions. The agency reports that the ERC has taken different initiatives, such as this video clip, to encourage them to apply further for ERC grants.
The BBC features the i2MOVE project that was awarded a € 7 million ERC Synergy grant to develop a microchip that could regulate appetite (see ERC press release). Animal trials of this electronic implant are about to begin.
The chip will be implanted in the abdomen and attached to the vagus (pneumogastric) nerve. It will then electrically stimulate the nerve to modulate signals associated with hormone release during eating and better regulate appetite.
The vagus nerve also regulates many other functions in the body: controlling the way we breathe, our heart rate or the secretion of acid in the digestive system. There are hopes that this project could also help to treat other diseases linked to neural or brain disturbances. Scientists expect human trials to begin within three years.
The Irish Times reports on a promising research project led by ERC Advanced grantee Prof. Luke O'Neill.
With his international team, he has discovered a way to halt damage and risk of death caused by blood poisoning.
Already tested in mice, the method could be used in humans given it is based on a drug prescribed for epilepsy.
The results of his research could be extended to conditions such as Type 2 diabetes.